Literature DB >> 7417907

Nonspecific arousal with noloxone.

F N Finkelstein, L H Bayne, R E Rangno.   

Abstract

The use of naloxone, the first narcotic antagonist devoid of agonist properties, has become the standard way of treating narcotic-induced coma and respiratory depression. This report concerns a patient in whom a narcotic effect was unlikely, but who nevetheless showed arousal after naloxone administration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7417907      PMCID: PMC1704556     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  10 in total

1.  The use of naloxone in the treatment of diazepam poisoning.

Authors:  E F Bell
Journal:  J Pediatr       Date:  1975-11       Impact factor: 4.406

2.  Opiate antagonist reverses the cardiovascular effects of inhalation anaesthesia.

Authors:  J O Arndt; E Freye
Journal:  Nature       Date:  1979-02-01       Impact factor: 49.962

3.  The effect of cirrhosis on the disposition and elimination of meperidine in man.

Authors:  U Klotz; T S McHorse; G R Wilkinson; S Schenker
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

4.  Treatment of drug overdosage with naloxone, a specific narcotic antagonist.

Authors:  L E Evans; C P Swainson; P Roscoe; L F Prescott
Journal:  Lancet       Date:  1973-03-03       Impact factor: 79.321

5.  The influence of naloxone on barbiturate anesthesia and toxicity in the rat.

Authors:  Z Fürst; F F Foldes; J Knoll
Journal:  Life Sci       Date:  1977-03-15       Impact factor: 5.037

6.  Antagonism of acupuncture analgesia in man by the narcotic antagonist naloxone.

Authors:  D J Mayer; D D Price; A Rafii
Journal:  Brain Res       Date:  1977-02       Impact factor: 3.252

7.  Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer.

Authors:  H H Szeto; C E Inturrisi; R Houde; S Saal; J Cheigh; M M Reidenberg
Journal:  Ann Intern Med       Date:  1977-06       Impact factor: 25.391

8.  Antagonism of general anesthesia by naloxone in the rat.

Authors:  A D Finck; S H Ngai; B A Berkowitz
Journal:  Anesthesiology       Date:  1977-04       Impact factor: 7.892

9.  Naloxone does not antagonize general anesthesia in the rat.

Authors:  M H Harper; P M Winter; B H Johnson; E I Eger
Journal:  Anesthesiology       Date:  1978-07       Impact factor: 7.892

10.  Naloxone.

Authors:  W R Martin
Journal:  Ann Intern Med       Date:  1976-12       Impact factor: 25.391

  10 in total
  3 in total

Review 1.  Naloxone: new therapeutic roles.

Authors:  B Milne; K Jhamandas
Journal:  Can Anaesth Soc J       Date:  1984-05

Review 2.  Enkephalins and Endorphins. Clinical, pharmacological and therapeutic implications.

Authors:  D L Copolov; R D Helme
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

Review 3.  Physical assessment and differential diagnosis of the poisoned patient.

Authors:  K R Olson; P R Pentel; M T Kelley
Journal:  Med Toxicol       Date:  1987 Jan-Feb
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.